HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamm, E. R. Articles by Piatigorsky, J. Search for Related Content PubMed PubMed Citation Articles by Tamm, E. R. Articles by Piatigorsky, J.

Modulation of Myocilin/TIGR Expression in Human Trabecular Meshwork

¹ From the Laboratory of Molecular and Developmental Biology and the ² Laboratory of Mechanisms of Ocular Diseases, National Eye Institute, National Institutes of Health, Bethesda, Maryland; the ³ Duke University Eye Center, Durham, North Carolina; and the ⁴ Mayo Clinic, Rochester, Minnesota.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
PURPOSE. To study factors that modulate myocilin/trabecular meshwork inducible glucocorticoid response protein (TIGR) mRNA expression in human trabecular meshwork (TM).

METHODS. mRNA from fresh TM of four human donors, from perfused anterior segment organ cultured TM of three donors, and from four primary TM cell lines of different donors was isolated. The full length cDNA of myocilin/TIGR was cloned from TM mRNA using a polymerase chain reaction approach and used as probe for northern blot analysis hybridization. Trabecular meshwork cell cultures were treated with transforming growth factor (TGF)-ß1 (1 ng/ml), dexamethasone (10^-7 M), and mechanical stretch (10%).

RESULTS. mRNA for myocilin/TIGR could be readily detected by northern blot analysis hybridization in 2 to 3 µg of total RNA from all fresh and all organ-cultured TM samples. In contrast, no mRNA for myocilin/TIGR could be detected in 20 µg of total RNA isolated from three different primary TM cell lines. Only one TM cell line had a baseline expression of myocilin/TIGR, which was 35- to 55-fold lower than that of fresh or organ-cultured TM samples. Treatment of TM cell cultures with dexamethasone for 1 day markedly increased expression of myocilin/TIGR mRNA, an effect that was even more pronounced after 3 days of treatment. Treatment with TGF-ß1 for 24 hours had no effect; however, after 3 and 12 days of treatment a 3.8- and 4-fold increase in myocilin/TIGR mRNA expression was observed. Expression of myocilin/TIGR mRNA was also increased after 10% mechanical stretch; however, in contrast to the effects of TGF-ß1, this effect was observed much earlier (8–24 hours) after treatment.

CONCLUSIONS. Dynamic mechanical stimuli maintain myocilin/TIGR expression in TM in situ and lack of these stimuli in monolayer cell cultures might be involved in downregulation of myocilin/TIGR expression.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Elevated intraocular pressure (IOP) in primary open-angle glaucoma (POAG) results from an increase in outflow resistance in the trabecular meshwork (TM), the major site of aqueous humor outflow. So far, the molecular mechanisms involved in normal and abnormal outflow resistance have not been identified. In some forms of POAG, myocilin, a protein that is also known as TM inducible glucocorticoid response protein (TIGR), might be involved. Recently, Stone et al.¹ identified three mutations in the gene for myocilin/TIGR, which lies within the interval on chromosome 1 that was originally associated with juvenile open angle-glaucoma (GLC1A).^{2 3 4} Subsequently, mutations in the same gene of patients with GLC1A-linked juvenile open-angle glaucoma were also reported by other researchers.^{5 6 7 8 9 10 11 12 13} Juvenile open-angle glaucoma refers to a subset of POAG that has an earlier age of onset, has a highly penetrant mode of inheritance, and is usually associated with high IOP that requires early surgical treatment.^{14 15 16}

Myocilin/TIGR was originally isolated from cultured human TM cells that had been treated long term with dexamethasone and, independently, from normal human retina.^{17 18 19} In addition to TM and retina, mRNA for myocilin/TIGR is expressed in various intraocular and extraocular tissues such as cornea, sclera, ciliary body, iris, heart, skeletal muscle, thymus, small intestine, colon, stomach, thyroid, and trachea.^{5 19 20 21 22 23} The normal role of myocilin/TIGR and the mechanisms by which mutations in this gene cause glaucoma are unknown. In contrast to findings in juvenile glaucoma, mutations in the myocilin/TIGR gene are present only in a minor percentage (4.6%) of patients with randomly screened adult forms of POAG.²⁴ Still, myocilin/TIGR might well also be involved in the pathogenesis of POAG in patients without mutations in the coding sequences of MYOC/TIGR. A recent immunohistochemical study showed increased staining for myocilin/TIGR in the TM of patients with adult-onset POAG when compared with age-matched control eyes.²⁵ We wished to clarify what factors other than dexamethasone might alter myocilin/TIGR synthesis in human TM. In the present study, we investigated the effects of various culture conditions, transforming growth factor-ß1 (TGF-ß1), and mechanical stretch on myocilin/TIGR mRNA expression.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Eyes from 11 human donors were obtained from the National Disease Research Interchange (NDRI, Philadelphia, PA) within 48 hours of death. Trabecular meshwork was dissected and immediately frozen from the eyes of four of the donors (age 1 day and 64, 78, and 84 years). Eyes from three other donors (age 60 years, 69 years, 71 years) were placed for 7 days in an anterior segment perfused organ culture system.²⁶ For monolayer cell cultures, the dissection and explant preparation was similar to that described previously.^{27 28 29} Primary cultures from four different donors (ages 19, 66, 72, and 80 years) were used. Cells were maintained at 37°C in Dulbecco’s modified Eagle’s medium (DMEM) that was supplemented with 20% fetal bovine serum (FBS) and gentamicin (all from Life Technologies, Gaithersburg, MD). Cell cultures that were at confluence for at least 7 days were treated daily for 8 hours and 1, 3, and 12 days with 1 ng/ml of human recombinant TGF-ß1 and for 8 hours and 1 and 3 days with 10^-7 M dexamethasone (all from Sigma, St. Louis, MO). In some experiments, TGF-ß1 was added in the presence of serum-free culture medium and after transferring the cells for 24 hours to this medium. Stretch experiments of monolayer cell cultures were performed as described previously.^{30 31} Cells were plated onto boats formed from silicone sheets, previously coated with laminin (Sigma), attached to end supports that were anchored into a support frame. Notches in the support frame were available to reset boats to a 10% linear stretch. Cells were plated at 1 x 10⁶ cells/sheet, 48 hours before experiments. In some experiments, the media were changed to serum-free DMEM 24 hours before mechanical stretching. The silicone sheets were stretched and maintained in the stretched position for 1, 2, 4, and 8 hours and 1 day, respectively. Each experiment was repeated at least three times.

RNA Analysis
Total RNA was isolated from fresh TM samples, from TM isolated from organ-cultured eyes, and from monolayer cell cultures using RNAzol (Tel Test; Friendswood, TX). RNA of TM cell cultures treated with dexamethasone for 3 days was used to isolate the full length cDNA of MYOC/TIGR. Reverse transcription–polymerase chain reaction (RT–PCR) was performed using a one-step RT–PCR kit (PCR-Superscript; Life Technologies) according to the manufacturer’s protocol. The RT–PCR was performed in a total volume of 50 µl for 30 minutes at 44°C (RT step), followed by melting at 94°C for 2 minutes, then 30 cycles of 50-second melting at 94°C, 75-second annealing at 55°C, and 2-minute extension at 72°C. After the last cycle, the polymerization step was extended for 10 minutes so that all strands were completed. The primers were designed according to the published structure of the human MYOC/TIGR gene¹ and were added at a concentration of 2 pmol. The sequences of the primer pairs were 5'-AGCCTCTGCAATGAGGTTC-3' and 5'-TTACAGCTTTTGCCCCAA-3'. The RT–PCR amplification product was gel-purified, cloned into pCR-Script (Stratagene, La Jolla, CA), and sequenced with fluorescent dideoxynucleotides on an Applied Biosystems (ABI) model 310 automated sequencer (Perkin–Elmer, Foster City, CA). For northern blot analysis experiments, RNA was separated on a 2.2 M formaldehyde–1.2% agarose gel and blotted onto a Duralon (Stratagene) membrane. After the transfer, the blot was cross-linked using a UV Stratalinker (Stratagene). Blots were hybridized with the full length cDNA for human MYOC/TIGR. The probe was labeled with ³²P-dCTP using a random prime kit (Life Technologies). Prehybridizations were performed at 68°C for 1 hour and hybridizations at 68°C overnight using 6x SSC, 5x Denhardt’s solution, and 0.5% sodium dodecyl sulfate (SDS). Membranes were washed twice for 15 minutes each with 2x SSC–0.1% SDS at 68°C and twice with 0.2x SSC–0.1% SDS at room temperature and autoradiographed using a Kodak XAR5 film at -80°C with an intensifying screen (1–2 days). To monitor the integrity of RNA, the relative amounts of RNA loaded on the gel, and the efficiency of transfer, membranes were hybridized to a cDNA probe for guinea pig 18S rRNA or stained with methylene blue. mRNA size was estimated by reference to the mobility of RNA size markers (Life Technologies) stained with methylene blue. Intensity of hybridization was determined by scanning densitometry using a Lumi-Imager and LumiQuant software (both from Boehringer, Mannheim, Germany). Autoradiograms were normalized to the relative intensity of the 18S band.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
The typical amount of total RNA that could be isolated from fresh TM from one adult eye was 1 to 3 µg. In all these samples, mRNA for myocilin/TIGR could be readily detected by northern blot analysis hybridization after exposure times of less than 1 hour (Fig. 1) . The intensity of the signal after normalization for the amount of RNA on the gel did not vary much between TM samples from different adult donors, with the exception of the TM of the 1-day-old donor. In that case, the band for myocilin/TIGR mRNA was considerably weaker (Fig. 2) . The amount of mRNA for myocilin/TIGR in TM from perfused organ cultures appeared to be similar to that seen in fresh TM (Fig. 3) . In contrast, no mRNA for myocilin/TIGR could be detected in 20 µg of total RNA isolated from three different primary TM cell lines (Figs. 1 3) . Only one TM cell line had a baseline expression of myocilin/TIGR, which was relatively 35- to 55-fold lower than that of fresh TM samples (Fig. 1) . In all primary TM cell lines, treatment with dexamethasone for 1 day markedly increased expression of myocilin/TIGR mRNA, an effect that was even more pronounced after 3 days of treatment (Fig. 4) . Treatment with TGF-ß1 for 24 hours had no effect (not shown), whereas after 3 and 12 days of treatment a 3.8- and 4-fold increase in myocilin/TIGR mRNA expression was observed (Figs. 5 6) . The same effect was observed when TGF-ß1 was added in the absence of serum (not shown). Expression of myocilin/TIGR mRNA was also increased after 10% mechanical stretch and was observed in the presence of serum (Fig. 7) or under serum-free conditions (Fig. 8) . In contrast to the effects of TGF-ß1, this effect was already observed 8 to 24 hours after treatment.

View larger version (57K): [in this window] [in a new window]   Figure 1. Northern blot analysis of myocilin/TIGR mRNA in fresh TM from both eyes of two human donors (lanes 1 and 2, age 78 years; lanes 3 and 4, age 64 years; OD: right eye, OS: left eye) and two primary TM cell lines (lanes 5 and 6) derived from two different human donors. For fresh TM, all RNA that could be isolated from each sample was loaded (1–2 µg of total RNA per lane); for cell cultures 20 µg of total RNA was loaded per lane. The exposure time of the autoradiograph was 1 hour. Relative amounts and integrity of RNA that were loaded were controlled by staining the membrane with methylene blue (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 55; lane 2, 17.5; lane 3, 38.5; lane 4, 35.7; lane 5, 0; and lane 6, 1. The size of a molecular marker is given in kilobases.

View larger version (45K): [in this window] [in a new window]   Figure 2. Northern blot analysis of myocilin/TIGR mRNA in TM from both eyes (OD: right eye; OS: left eye) of a 1-day-old human donor (lane 1) and the left eye (OS, lane 2) from an 84-year-old donor. All RNA that could be isolated from each sample was loaded (1–2 µg of total RNA per lane). Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 1; lane 2, 42. The size of a molecular marker is given in kilobases.

View larger version (61K): [in this window] [in a new window]   Figure 3. Northern blot analysis of myocilin/TIGR mRNA in TM from a perfused anterior segment organ-cultured eye (lane 1) and two primary TM cell lines (lanes 2 and 3) derived from two human donors different from those shown in Figure 1 . For organ-cultured TM, all RNA that could be isolated was loaded (2–3 µg of total RNA); for cell cultures 20 µg of total RNA was loaded per lane. Exposure times were 1 hour and 1 week as indicated. Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). The size of a molecular marker is given in kilobases.

View larger version (75K): [in this window] [in a new window]   Figure 4. Northern blot analysis of myocilin/TIGR mRNA in TM monolayer cell culture after treatment with dexamethasone (10-7 M) for 8 hours, 1 day, and 3 days. Twenty micrograms of total RNA was loaded per lane. The exposure time of the autoradiograph was 24 hours. Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 1; lane 2, 3; lane 3, 38; and lane 4, 96. The size of a molecular marker is given in kilobases. Co, control.

View larger version (60K): [in this window] [in a new window]   Figure 5. Northern blot analysis of myocilin/TIGR mRNA in TM monolayer cell culture after treatment with TGF-ß1 (1 ng/ml) for 3 days. Twenty micrograms of total RNA was loaded per lane. The exposure time of the autoradiograph was 24 hours. Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 1; and lane 2, 3.8. The size of a molecular marker is given in kilobases. Co, control.

View larger version (37K): [in this window] [in a new window]   Figure 6. Northern blot analysis of myocilin/TIGR mRNA in TM monolayer cell culture after treatment with TGF-ß1 (1 ng/ml) for 12 days. Twenty micrograms of total RNA was loaded per lane. The exposure time of the autoradiograph was 24 hours. Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 1; and lane 2, 4. The size of a molecular marker is given in kilobases. Co, control.

View larger version (78K): [in this window] [in a new window]   Figure 7. Northern blot analysis of myocilin/TIGR mRNA in TM monolayer cell culture after mechanical stretch (10%) for 1, 2, 4, and 8 hours in medium supplemented with 20% FBS. Twenty micrograms of total RNA was loaded per lane. The exposure time of the autoradiograph was 24 hours. Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 1; lane 2, 0.72; lane 3, 1.3; lane 4, 3.4; and lane 5, 2.7. The size of a molecular marker is given in kilobases. Co, control.

View larger version (98K): [in this window] [in a new window]   Figure 8. Northern blot analysis of myocilin/TIGR mRNA in TM monolayer cell culture after mechanical stretch (10%) for 8 and 24 hours in serum-free medium. Twenty micrograms of total RNA was loaded per lane. The exposure time of the autoradiograph was 24 hours. Relative amounts and integrity of RNA that were loaded were controlled by reprobing the membrane with a cDNA probe specific for guinea pig 18S ribosomal RNA (lower panel). Relative densitometric intensities (normalized to 18S RNA) of the myocilin/TIGR bands are as follows: lane 1, 1; lane 2, 3.2; and lane 3, 11. The size of a molecular marker is given in kilobases. Co, control.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

One obvious difference between TM cells in monolayer culture and TM cells in situ is the fact that the latter are under the influence of mechanical factors. In fresh eyes and perfused anterior segment organ cultures, pressure and flow of aqueous humor or culture medium may have caused dynamic interactions to be set up between TM cells and their associated extracellular matrix components. In support of this hypothesis we observed that TM cells in monolayer culture are induced to synthesize increasing amounts of myocilin/TIGR mRNA on mechanical stretch. This induction occurs faster than that we observed with dexamethasone and that has been reported to require prolonged treatment of TM cells for days.^{18 32} It is tempting to speculate that response to mechanical stretch indicates that myocilin/TIGR is involved in the stability of the cytoskeleton or in cellular adhesion in the TM. Sequence analysis of myocilin/TIGR indicates that the amino terminus has homology with non–muscle myosin.^{19 32} The myosin-like domain might be associated with the cytoskeleton or the cell membrane, but experimental data in support of this hypothesis are lacking. Recent studies reported that myocilin/TIGR is localized intracellularly around the nucleus and within the cytoplasm, but thus far an association with specific subcellular structures has not been defined.^{33 34}

We recently observed distinct changes in protein and mRNA expression in TM cells after mechanical stretch.³¹ The expression of the immediate-early gene c-fos was depressed, whereas the level of mRNA for c-jun was unchanged. In addition, actin filaments within TM cells rearranged from a diffuse network to complex geodesic patterns.³¹ Such a rearrangement of actin filaments has been reported to be highly characteristic for TM cells after long-term treatment with dexamethasone.³⁵ Because both mechanical stretch and treatment with dexamethasone induce myocilin/TIGR expression, we hypothesized that this induction might be associated with a rearrangement of the actin cytoskeleton. Another agent that causes changes in TM actin is TGF-ß1, which induces -smooth muscle actin positive stress fibers and an overall contractile phenotype.²⁸ Our studies on the effects of TGF-ß1 on myocilin/TIGR expression in TM indeed found an increase in mRNA after treatment. However, the results showed only a moderate increase and much less than that observed after treatment with dexamethasone. Still, the time course of myocilin/TIGR induction after TGF-ß treatment was comparable to that observed previously for the induction of -smooth muscle actin.²⁸ Clearly, further studies are required to clarify whether there is a direct association between both events.

We concluded that dynamic mechanical stimuli maintain myocilin/TIGR expression in TM in situ and that lack of these stimuli in monolayer cell cultures might be involved in the downregulation of myocilin/TIGR expression. Myocilin/TIGR has been found in increasing amounts in the TM of patients with adult-onset POAG but also in patients with glaucoma associated with pseudoexfoliation,²⁵ a secondary type of open-angle glaucoma. Our results might indicate that myocilin/TIGR increases after a mechanical deformation of the TM that is caused by high IOP and that high amounts of myocilin/TIGR in eyes with glaucoma reflect a symptom rather than the cause of high IOP.

	Acknowledgements

 
The authors thank Terete Borrás (Duke University Eye Center, Durham, NC) for providing the guinea pig 18S ribosomal RNA cDNA probe.

	Footnotes

 
Supported by grants from the Deutsche Forschungsgemeinschaft (Ta 115/8-1 and Ta 115/11-1); the American Health Assistance Foundation (ERT); the National Eye Institute (EY01894); and Research to Prevent Blindness (DLE).

Submitted for publication November 30, 1998; revised April 14, 1999; accepted June 3, 1999.

Commercial relationships policy: N.

Presented at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May, 1998.

Corresponding author: Ernst R. Tamm, Department of Anatomy II, University of Erlangen–Nürnberg, Universitätsstr. 19, D-91054 Erlangen, Germany. E-mail: ertamm{at}anatomie.uni-erlangen.de

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Stone, EM, Fingert, JH, Alward, WLM, et al (1997) Identification of a gene that causes primary open angle glaucoma Science 275,668-670[Abstract/Free Full Text]
2. Sheffield, VC, Stone, EM, Alward, WL, et al (1993) Genetic linkage of familial open angle glaucoma to chromosome 1q21–q31 Nat Genet 4,47-50[Medline][Order article via Infotrieve]
3. Wiggs, JL, Haines, JL, Paglinauan, C, Fine, A, Sporn, C, Lou, D. (1994) Genetic linkage of autosomal dominant juvenile glaucoma to 1q21–q31 in three affected pedigrees Genomics 15,299-303
4. Richards, JE, Lichter, PR, Boehnke, M, et al (1994) Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq Am J Hum Genet 54,62-70[Medline][Order article via Infotrieve]
5. Adam, MF, Belmouden, A, Binisti, P, et al (1997) Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma Hum Mol Genet 12,2091-2097
6. Stoilova, D, Child, A, Brice, G, Crick, RP, Fleck, BW, Sarfarazi, M. (1997) Identification of a new "TIGR" mutation in a family with juvenile-onset primary open angle glaucoma Ophthalmic Genet 18,109-118[Medline][Order article via Infotrieve]
7. Suzuki, Y, Shirato, S, Taniguchi, F, Ohara, K, Nishimaki, K, Ohta, S. (1997) Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan Am J Hum Genet 61,1202-1204[Medline][Order article via Infotrieve]
8. Kee, C, Ahn, BH (1997) TIGR gene in primary open-angle glaucoma and steroid-induced glaucoma Korean J Ophthalmol 11,75-78[Medline][Order article via Infotrieve]
9. Michels–Rautenstrauss, KG, Mardin, CY, Budde, WM, et al (1998) Juvenile open angle glaucoma: fine mapping of the TIGR gene to 1q24.3-q25.2 and mutation analysis Hum Genet 102,103-106[Medline][Order article via Infotrieve]
10. Mansergh, FC, Kenna, PF, Ayuso, C, Kiang, AS, Humphries, P, Farrrrar, GJ (1998) Novel mutations in the TIGR gene in early and late onset open angle glaucoma Hum Mutat 11,244-251[Medline][Order article via Infotrieve]
11. Brezin, AP, Adam, MF, Belmouden, A, et al (1998) Founder effect in GLC1A-linked familial open-angle glaucoma in Northern France Am J Med Genet 76,438-445[Medline][Order article via Infotrieve]
12. Angius, A, De Gioia, E, Loi, A, et al (1998) A novel mutation in the GLC1A gene causes juvenile open-angle glaucoma in 4 families from the Italian region of Puglia Arch Ophthalmol 116,793-797[Abstract/Free Full Text]
13. Richards, JE, Ritch, R, Lichter, PL, et al (1998) Novel trabecular meshwork inducible glucocorticoid response mutation in an eight-generation juvenile-onset primary open-angle glaucoma pedigree Ophthalmology 105,1698-1707[Medline][Order article via Infotrieve]
14. Wiggs, JL, Del Bono, EA, Schuman, JS, Hutchinson, BT, Walton, DS (1995) Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21–q31 Ophthalmology 102,1782-1789[Medline][Order article via Infotrieve]
15. Wiggs, JL (1995) Genetics of glaucoma Wiggs, JL eds. Molecular Genetics of Ocular Disease ,83-98 Wiley–Liss New York.
16. Johnson, AT, Alward, WLM, Sheffield, VC, Stone, EM (1996) Genetics and glaucoma Ritch, R Shields, MB Krupin, T eds. The Glaucomas 2nd ed. ,39-54 Mosby St. Louis.
17. Nguyen, TD, Huang, W, Bloom, E, Polansky, JR (1993) Glucocorticoid (GC) effects on HTM cells: molecular biology approaches Lütjen–Drecoll, E eds. Basic Aspects of Glaucoma Research III ,331-343 Schattauer New York.
18. Polansky, JR, Fauss, DJ, Chen, P, et al (1997) Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response (TIGR) gene product Ophthalmologica 211,126-139[Medline][Order article via Infotrieve]
19. Kubota, R, Noda, S, Wang, Y, et al (1997) A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression and chromosomal mapping Genomics 41,360-369[Medline][Order article via Infotrieve]
20. Ortego, J, Escribano, J, Coca–Prados, M. (1997) Cloning and characterization of subtracted cDNAs from human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin FEBS Lett 413,349-353[Medline][Order article via Infotrieve]
21. Tomarev, SI, Tamm, ER, Chang, B. (1998) Characterization of the mouse myoc/tigr gene Biochem Biophys Res Commun 245,887-893[Medline][Order article via Infotrieve]
22. Fingert, JH, Ying, L, Swiderski, R, et al (1998) Characterization and comparison of the human and mouse GLC1A glaucoma genes Genome Res 8,377-384[Abstract/Free Full Text]
23. Takahashi, H, Noda, S, Imamura, Y, et al (1998) Mouse myocilin (Myoc) gene expression in ocular tissues Biochem Biophys Res Commun 248,104-109[Medline][Order article via Infotrieve]
24. Alward, WL, Fingert, JH, Coote, MA, et al (1998) Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene N Engl J Med 338,1022-1027[Abstract/Free Full Text]
25. Lütjen–Drecoll, E, May, CA, Polansky, JR, Johnson, DH, Bloemendal, H, Nguyen, TD (1998) Localization of the stress proteins B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork Invest Ophthalmol Vis Sci 39,517-525[Abstract/Free Full Text]
26. Johnson, DH, Tschumper, RC (1987) Human trabecular meshwork organ culture: a new method Invest Ophthalmol Vis Sci 28,945-953[Abstract/Free Full Text]
27. Erickson–Lamy, K, Schroeder, A, Epstein, DL (1992) Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells Invest Ophthalmol Vis Sci 33,2631-2640[Abstract/Free Full Text]
28. Tamm, ER, Siegner, A, Baur, A, Lütjen–Drecoll, E. (1996) Transforming growth factor-ß1 induces -smooth muscle-actin expression in cultured human and monkey trabecular meshwork Exp Eye Res 62,389-397[Medline][Order article via Infotrieve]
29. O’Brien, ET, Perkins, SL, Roberts, BC, Epstein, DL (1998) Dexamethasone inhibits trabecular cell retraction Invest Ophthalmol Vis Sci 62,675-688
30. Mitton, KP, Tumminia, SJ, Arora, J, Zelenka, P, Epstein, DL, Russell, P. (1997) Transient loss of B-crystallin: an early cellular response to mechanical stretch Biochem Biophys Res Commun 235,69-73[Medline][Order article via Infotrieve]
31. Tumminia, SJ, Mitton, KP, Arora, J, Zelenka, P, Epstein, DL, Russell, P. (1998) Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells Invest Ophthalmol Vis Sci 39,1361-1371[Abstract/Free Full Text]
32. Nguyen, TD, Chen, P, Huang, WD, Chen, H, Johnson, D, Polansky, JR (1998) Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells J Biol Chem 273,6341-6350[Abstract/Free Full Text]
33. Clark, AF, Steely, H, Dickerson, JEJ, English–Write, S, Fingert, J, Stone, EM. (1998) Expression of GLC1A (myocilin, TIGR) in the trabecular meshwork [ARVO Abstract] Invest Ophthalmol Vis Sci 39(4),S437Abstract nr 2022
34. Stamer, WD, Roberts, BC, Howell, DN, Epstein, DL (1998) Isolation, culture, and characterization of endothelial cells from Schlemm’s canal Invest Ophthalmol Vis Sci 39,1804-1812[Abstract/Free Full Text]
35. Clark, AF, Wilson, K, McCartney, MD, Miggans, ST, Kunkle, M, Howe, W. (1994) Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells Invest Ophthalmol Vis Sci 35,281-294[Abstract/Free Full Text]

This article has been cited by other articles:

				P. Russell, J. Z. Gasiorowski, P. F. Nealy, and C. J. Murphy Response of Human Trabecular Meshwork Cells to Topographic Cues on the Nanoscale Level Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 629 - 635. [Abstract] [Full Text] [PDF]

				G. Schlunck, H. Han, T. Wecker, D. Kampik, T. Meyer-ter-Vehn, and F. Grehn Substrate Rigidity Modulates Cell Matrix Interactions and Protein Expression in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 262 - 269. [Abstract] [Full Text] [PDF]

				D. B. Gould, M. Reedy, L. A. Wilson, R. S. Smith, R. L. Johnson, and S. W. M. John Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma Mol. Cell. Biol., November 15, 2006; 26(22): 8427 - 8436. [Abstract] [Full Text] [PDF]

				J C H Tan, F B Kalapesi, and M T Coroneo Mechanosensitivity and the eye: cells coping with the pressure. Br. J. Ophthalmol., March 1, 2006; 90(3): 383 - 388. [Abstract] [Full Text] [PDF]

				K. M. Hardy, E. A. Hoffman, P. Gonzalez, B. S. McKay, and W. D. Stamer Extracellular Trafficking of Myocilin in Human Trabecular Meshwork Cells J. Biol. Chem., August 12, 2005; 280(32): 28917 - 28926. [Abstract] [Full Text] [PDF]

				V. Vittal, A. Rose, K. E. Gregory, M. J. Kelley, and T. S. Acott Changes in Gene Expression by Trabecular Meshwork Cells in Response to Mechanical Stretching Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2857 - 2868. [Abstract] [Full Text] [PDF]

				T. Aung, V. H. K. Yong, P. T. K. Chew, S. K. L. Seah, G. Gazzard, P. J. Foster, and E. N. Vithana Molecular Analysis of the Myocilin Gene in Chinese Subjects with Chronic Primary-Angle Closure Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1303 - 1306. [Abstract] [Full Text] [PDF]

				M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 223 - 234. [Abstract] [Full Text] [PDF]

				D. B. Gould, L. Miceli-Libby, O. V. Savinova, M. Torrado, S. I. Tomarev, R. S. Smith, and S. W. M. John Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma Mol. Cell. Biol., October 15, 2004; 24(20): 9019 - 9025. [Abstract] [Full Text] [PDF]

				M. Obazawa, Y. Mashima, N. Sanuki, S. Noda, J. Kudoh, N. Shimizu, Y. Oguchi, Y. Tanaka, and T. Iwata Analysis of Porcine Optineurin and Myocilin Expression in Trabecular Meshwork Cells and Astrocytes from Optic Nerve Head Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2652 - 2659. [Abstract] [Full Text] [PDF]

				J. Gottanka, D. Chan, M. Eichhorn, E. Lutjen-Drecoll, and C. R. Ethier Effects of TGF-{beta}2 in Perfused Human Eyes Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 153 - 158. [Abstract] [Full Text] [PDF]

				J. M. B. Bradley, M. J. Kelley, A. Rose, and T. S. Acott Signaling Pathways Used in Trabecular Matrix Metalloproteinase Response to Mechanical Stretch Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5174 - 5181. [Abstract] [Full Text] [PDF]

				A. Goldwich, C. R. Ethier, D. W.-H. Chan, and E. R. Tamm Perfusion with the Olfactomedin Domain of Myocilin Does Not Affect Outflow Facility Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1953 - 1961. [Abstract] [Full Text] [PDF]

				N. Wang, S. K. Chintala, M. E. Fini, and J. S. Schuman Ultrasound Activates the TM ELAM-1/IL-1/NF-{kappa}B Response: A Potential Mechanism for Intraocular Pressure Reduction after Phacoemulsification Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1977 - 1981. [Abstract] [Full Text] [PDF]

				T. Borras, T. V. Morozova, S. L. Heinsohn, R. F. Lyman, T. F. C. Mackay, and R. R. H. Anholt Transcription Profiling in Drosophila Eyes That Overexpress the Human Glaucoma-Associated Trabecular Meshwork-Inducible Glucocorticoid Response Protein/Myocilin (TIGR/MYOC) Genetics, February 1, 2003; 163(2): 637 - 645. [Abstract] [Full Text] [PDF]

				H. Takase, S. Sugita, D. J. Rhee, Y. Imai, C. Taguchi, Y. Sugamoto, Y. Tagawa, J. Nishihira, P. Russell, and M. Mochizuki The Presence of Macrophage Migration Inhibitory Factor in Human Trabecular Meshwork and its Upregulatory Effects on the T Helper 1 Cytokine Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2691 - 2696. [Abstract] [Full Text] [PDF]

				T. Borras, L. L. S. Rowlette, E. R. Tamm, J. Gottanka, and D. L. Epstein Effects of Elevated Intraocular Pressure on Outflow Facility and TIGR/MYOC Expression in Perfused Human Anterior Segments Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 33 - 40. [Abstract] [Full Text] [PDF]

				M. S. Filla, X. Liu, T. D. Nguyen, J. R. Polansky, C. R. Brandt, P. L. Kaufman, and D. M. Peters In Vitro Localization of TIGR/MYOC in Trabecular Meshwork Extracellular Matrix and Binding to Fibronectin Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 151 - 161. [Abstract] [Full Text] [PDF]

				A. R. Shepard, N. Jacobson, J. H. Fingert, E. M. Stone, V. C. Sheffield, and A. F. Clark Delayed Secondary Glucocorticoid Responsiveness of MYOC in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3173 - 3181. [Abstract] [Full Text] [PDF]

				C. Maihofner, U. Schlotzer-Schrehardt, H. Guhring, H. U. Zeilhofer, G. O. H. Naumann, A. Pahl, C. Mardin, E. R. Tamm, and K. Brune Expression of Cyclooxygenase-1 and -2 in Normal and Glaucomatous Human Eyes Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2616 - 2624. [Abstract] [Full Text] [PDF]

				M. P. Fautsch and D. H. Johnson Characterization of Myocilin-Myocilin Interactions Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2324 - 2331. [Abstract] [Full Text] [PDF]

				A. F. Clark, H. T. Steely, J. E. Dickerson Jr, S. English-Wright, K. Stropki, M. D. McCartney, N. Jacobson, A. R. Shepard, J. I. Clark, H. Matsushima, et al. Glucocorticoid Induction of the Glaucoma Gene MYOC in Human and Monkey Trabecular Meshwork Cells and Tissues Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1769 - 1780. [Abstract] [Full Text] [PDF]

				J. M. B. Bradley, M. J. Kelley, X. Zhu, A. M. Anderssohn, J. P. Alexander, and T. S. Acott Effects of Mechanical Stretching on Trabecular Matrix Metalloproteinases Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1505 - 1513. [Abstract] [Full Text]

				N. Jacobson, M. Andrews, A. R. Shepard, D. Nishimura, C. Searby, J. H. Fingert, G. Hageman, R. Mullins, B. L. Davidson, Y. H. Kwon, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor Hum. Mol. Genet., January 1, 2001; 10(2): 117 - 125. [Abstract] [Full Text] [PDF]

				M. P. Fautsch, C. K. Bahler, D. J. Jewison, and D. H. Johnson Recombinant TIGR/MYOC Increases Outflow Resistance in the Human Anterior Segment Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4163 - 4168. [Abstract] [Full Text]

				J. Ueda, K. K. Wentz–Hunter, E. L. Cheng, T. Fukuchi, H. Abe, and B. Y.J.T. Yue Ultrastructural Localization of Myocilin in Human Trabecular Meshwork Cells and Tissues J. Histochem. Cytochem., October 1, 2000; 48(10): 1321 - 1330. [Abstract] [Full Text]

				R. E. Swiderski, J. L. Ross, J. H. Fingert, A. F. Clark, W. L. M. Alward, E. M. Stone, and V. C. Sheffield Localization of MYOC Transcripts in Human Eye and Optic Nerve by In Situ Hybridization Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3420 - 3428. [Abstract] [Full Text]

				D. H. Johnson Myocilin and Glaucoma: A TIGR by the Tail? Arch Ophthalmol, July 1, 2000; 118(7): 974 - 978. [Abstract] [Full Text] [PDF]